Influenza Vaccines
A DrugBank category of 70 drugs. 70 of them are approved.
- ATC classification
- Part of
- Viral Vaccines
- Drugs
- Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated)
- Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated)
- Influenza A Virus A/California/122/2022 SAN-022 (H3N2) antigen (formaldehyde inactivated)
- Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen
- Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated)
- Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated)
- Influenza A virus A/Cambodia/e0826360/2020 IVR-224 (H3N2) antigen (formaldehyde inactivated)
- Influenza A virus A/Cambodia/e0826360/2020 IVR-224 (H3N2) antigen (propiolactone inactivated)
- Influenza A virus A/Croatia/10136RV/2023 X-425A (H3N2) antigen (formaldehyde inactivated)
- Influenza A virus A/Croatia/10136RV/2023 X-425A (H3N2) antigen (propiolactone inactivated)
- Influenza A virus A/Croatia/10136RV/2023 X-425A (H3N2) antigen (UV, formaldehyde inactivated)
- Influenza A virus A/Darwin/11/2021 (H3N2) antigen (MDCK cell derived, propiolactone inactivated)
- Influenza A virus A/Darwin/6/2021 (H3N2) recombinant hemagglutinin antigen
- Influenza A virus A/Darwin/6/2021 IVR-227 (H3N2) antigen (formaldehyde inactivated)
- Influenza A virus A/Darwin/6/2021 IVR-227 (H3N2) antigen (propiolactone inactivated)
- Influenza A virus A/Darwin/9/2021 IVR-228 (H3N2) antigen (UV, formaldehyde inactivated)
- Influenza A virus A/Darwin/9/2021 SAN-010 (H3N2) antigen (formaldehyde inactivated)
- Influenza A virus A/Delaware/55/2019 CVR-45 (H1N1) antigen (MDCK cell derived, propiolactone inactivated)
- Influenza A virus A/District of Columbia/27/2023 (H3N2) recombinant hemagglutinin antigen
- Influenza A virus A/Georgia/12/2022 CVR-167 (H1N1) Antigen (MDCK cell derived, propiolactone inactivated)
- Influenza A virus A/Hong Kong/2671/2019 IVR-208 (H3N2) antigen (formaldehyde inactivated)
- Influenza A virus A/Massachusetts/18/2022 (H3N2) recombinant hemagglutinin antigen
- Influenza A virus A/Norway/16606/2021 (H3N2) live (attenuated) antigen
- Influenza A virus A/Norway/31694/2022 (H1N1) live (attenuated) antigen
- Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen
What you can answer from here — as of August 12, 2022
Which targets do Influenza Vaccines share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account